Comments

Regeneron Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

REGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$571.36

-2.80-0.49%

At close: -

$572.90

1.540.27%

After Hours: 7:55 PM EDT

The dividend Ex-Date is in 5 days

Regeneron Pharmaceuticals (REGN) Forecast

News Earnings Regeneron Pharmaceuticals (REGN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Regeneron Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:REGN | Benzinga

Explore Regeneron Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REGN.

Open	$576.35
Close	$571.36
Volume / Avg.	1.66M / 1.11M
Day Range	$567.59 - $580.56
52 Wk Range	520.50 - 1.21K
Market Cap	$61.85B
P/E Ratio	14.52
Dividend Yield	0.62%
Exchange	NASDAQ
RSI	47
Short Interest	2.82%
Days to Cover	2.41

Recent News

Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030

Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states.

Vandana Singh

Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards?

Only about 50% of S&P 500 stocks trade above their 200-day average, signaling narrow breadth even as the index rallies 22% since April.

Piero Cingari

This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$576.35
Close	$571.36
Volume / Avg.	1.66M / 1.11M
Day Range	$567.59 - $580.56
52 Wk Range	520.50 - 1.21K
Market Cap	$61.85B
P/E Ratio	14.52
Dividend Yield	0.62%
Exchange	NASDAQ
RSI	47
Short Interest	2.82%
Days to Cover	2.41

About Regeneron Pharmaceuticals, Inc.

Sector

Health Care

Industry

Biotechnology

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, c...

Got Questions? Ask

What is REGN's 200-day MA?

What are analysts' targets for REGN?

What is REGN's all-time low price?

What is REGN's P/S ratio?

What is REGN's Sharpe ratio?

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Regeneron Pharmaceuticals (REGN) stock?

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Who are Regeneron Pharmaceuticals (REGN) competitors?

Other companies in Regeneron Pharmaceuticals’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?

Regeneron Pharmaceuticals has a consensus price target of $923.42.

What is the current price for Regeneron Pharmaceuticals (REGN)?

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $572.9 last updated May 14, 2025 at 7:55 PM EDT.

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

The next Regeneron Pharmaceuticals (REGN) dividend date is projected to be Tuesday, May 20, 2025.

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

Regeneron Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Regeneron Pharmaceuticals (REGN) going to split?

There is no upcoming split for Regeneron Pharmaceuticals.

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.